A Bivalent Ligand (KDAN-18) Containing δ-Antagonist and κ-Agonist Pharmacophores Bridges δ2 and κ1 Opioid Receptor Phenotypes
- 23 September 2004
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (6), 1713-1716
- https://doi.org/10.1021/jm034234f
Abstract
To characterize δ- and κ-opioid receptor phenotypes, bivalent ligands (KDAN series) containing δ-antagonist (naltrindole) and κ1-agonist (ICI-199,441) pharmacophores were synthesized and evaluated by the intrathecal route using the mouse tail-flick assay and binding studies. The data have suggested that KDAN-18 (2) bridges phenotypic δ2- and κ1-receptors. A conceptual model is presented to explain the organizational differences between the opioid receptors that give rise to the phenotypes (δ1, δ2, κ1, κ2).Keywords
This publication has 16 references indexed in Scilit:
- A Bivalent Ligand (KDN-21) Reveals Spinal δ and κ Opioid Receptors Are Organized as Heterodimers That Give Rise to δ1 and κ2 Phenotypes. Selective Targeting of δ−κ HeterodimersJournal of Medicinal Chemistry, 2004
- Identity of the putative δ1-opioid receptor as a δ–κ heteromer in the mouse spinal cordEuropean Journal of Pharmacology, 2003
- Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequencesBiochemical Journal, 2002
- Opioids and Their Complicated Receptor ComplexesNeuropsychopharmacology, 2000
- Dimerization of the δ Opioid Receptor:Published by Elsevier BV ,1997
- A highly selective δ1-opioid receptor antagonist: 7-benzylidenenaltrexoneEuropean Journal of Pharmacology, 1992
- Structure activity studies related to 2-(3,4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-ethyl]acetamides: a novel series of potent and selective .kappa.-opioid agonistsJournal of Medicinal Chemistry, 1991
- Central effects of the potent and highly selective μ opioid antagonist (CTOP) in miceEuropean Journal of Pharmacology, 1988
- Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonistsLife Sciences, 1987
- Benzeneacetamide amines: structurally novel non-m.mu. opioidsJournal of Medicinal Chemistry, 1982